180 Wealth Advisors’s Anavex Life Sciences AVXL Stock Holding History
Bought
Maintained
Sold
Other funds holding AVXL
180 Wealth Advisors's AVXL Position: Q3 2026 in Review
180 Wealth Advisors reduced its Anavex Life Sciences (AVXL) stake by 10% in Q3 2026, selling an estimated $20.3K and leaving 63,690 shares worth $129K. The position accounts for 0.01% of the portfolio, ranked #480.
180 Wealth Advisors first reported a position in AVXL in Q1 2025 and has held it in 7 quarters since. The position peaked at $418K in Q4 2025. 165 funds tracked by Wall St. Rank hold AVXL as of Q3 2026.
- 180 Wealth Advisors held 63,690 shares of Anavex Life Sciences worth $129K as of Q3 2026.
- 180 Wealth Advisors sold 7,340 Anavex Life Sciences shares in Q3 2026, an estimated $20.3K.
- Anavex Life Sciences made up 0.01% of 180 Wealth Advisors's portfolio in Q3 2026, its #480 holding.
- 180 Wealth Advisors first reported a position in Anavex Life Sciences in Q1 2025 and has held it in 7 quarters since.
- 180 Wealth Advisors's Anavex Life Sciences position peaked at $418K in Q4 2025.
- 165 funds tracked by Wall St. Rank held Anavex Life Sciences as of Q3 2026.
Based on 180 Wealth Advisors's 13F filing for Q3 2026, filed 3 Nov 2026.